Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BCAS1 resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Additionally we are shipping BCAS1 Antibodies (76) and many more products for this protein.
Showing 7 out of 8 products:
Two transcripts with regulation from days 7 to 28 in the 1-methyl-4-phenyl-tetrahydropyridine treated groups, are identified: brain specific (show CALY Proteins) angiogenesis inhibitor associated protein 3 (show HSPB3 Proteins) (Baiap3 (show BAIAP3 Proteins)) and breast carcinoma amplified sequence 1 (Bcas1).
This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene.
amplified and overexpressed in breast cancer
, breast carcinoma-amplified sequence 1
, novel amplified in breast cancer 1
, amplified in breast cancer 1
, breast carcinoma-amplified sequence 1 homolog
, novel amplified in breast cancer 1 homolog
, band 83
, breast carcinoma amplified sequence 1
, breast carcinoma-amplified sequence 1-like